University of Miami

University of Miami

University of Miami

Overview
Date Founded

1925

Headquarters

P.O. Box 248026, Coral Gables, FL, 33124-6914, United States

Employees (Worldwide)

25.8K

Industries

Schools & Student Services

Company Description

The University of Miami is a private research university in Coral Gables, Florida. As of 2019, the university enrolls 17,811 students in 12 separate colleges/schools, including the Leonard M. Miller School of Medicine in Miami's Health District, a law school on the main campus, and the Rosenstiel School of Marine and Atmospheric Science focused on the study of oceanography and atmospheric sciences on Virginia Key, with research facilities at the Richmond Facility in southern Miami-Dade County. The university offers 132 undergraduate, 148 master's, and 67 doctoral degree programs, of which 63 are research/scholarship and four professional areas of study. Over the years, the university's students have represented all 50 states and close to 150 foreign countries. With more than 16,000 full- and part-time faculty and staff, UM is a top 10 employer in Miami-Dade County. UM's main campus in Coral Gables has 239 acres and over 5.7 million square feet of buildings. Research is a component of each academic division, with UM attracting $358.9 million in sponsored research grants in FY 2019. UM offers a large library system with over 3.9 million volumes and exceptional holdings in Cuban heritage and music. UM also offers a wide range of student activities, including fraternities and sororities, a student newspaper and a radio station. UM's intercollegiate athletic teams, collectively known as the Miami Hurricanes, compete in Division I of the National Collegiate Athletic Association. UM's football team has won five national championships since 1983 and its baseball team has won four national championships since 1982.

Contact Data
Trying to get in touch with decision makers at University of Miami? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Distinguished Alumni
Dinaz Dadyburjor is now Managing Partner, Private Funds at Brookfield Asset Management, Inc.
Eugene Matthew Schaefer is now President for Miami at Bank of America Corp.
Jeff Benck is now President & Chief Executive Officer at Benchmark Electronics, Inc.
Paths to University of Miami
Potential Connections via
Relationship Science
You
University of Miami
Recent Transactions
Details Hidden

University of Miami purchases Cedars Healthcare Group Ltd. from HCA, Inc.

Transaction Advisors
Legal Advisor

Advised onUniversity of Miami purchases Cedars Healthcare Group Ltd. from HCA, Inc.

Advisors & Consultants
Consultant
Consultant

Partner at Latham & Watkins LLP

Real Estate Agent

Founder at Blanca Commercial Real Estate, Inc.

Consultant

Health Care Leader at RSM US LLP

Clients

Seattle Genetics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing monoclonal antibody-based therapies for the treatment of cancer and autoimmune diseases. Its lead product, SGN-35, is in pivotal trial for patients with relapsed or refractory hodgkin lymphoma. The company's other product candidates in various stages of clinical trials include dacetuzumab (SGN-40), a humanized anti-CD40 antibody; lintuzumab (SGN-33), a humanized anti-CD33 antibody; SGN-70, a humanized anti-CD70 antibody for the treatment of autoimmune diseases; SGN-75, which is in Phase I clinical trials for metastatic renal cell carcinoma and non-Hodgkin lymphoma; ASG-5ME, a preclinical antibody-drug conjugate product candidate for the treatment of solid tumors; and SGN-19A, a preclinical antibody-drug conjugate product candidate for the treatment of hematologic malignancies. It has collaborations with Bayer Pharmaceuticals Corporation; Celldex Therapeutics, Inc.; Daiichi Sankyo Co., Ltd.; Genentech; GlaxoSmithKline LLC; MedImmune, Inc.; Millennium; PSMA Development Company LLC; and Genmab A/S. The company also has an antibody-drug conjugates co-development agreement with Agensys, Inc. The company was founded in 1998 and is headquartered in Bothell, Washington.

FibroGen, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutics. It focuses on the hypoxia-inducible factor and connective tissue growth factor biology to develop medicines for the treatment of anemia, fibrotic disease, and cancer. The company was founded by Thomas B. Neff on September 29, 1993 and is headquartered in San Francisco, CA.

The Consortium for Ocean Leadership Inc., a non-profit organization, represents public and private ocean research and education institutions, aquaria and industry with the mission to advance research, education and sound ocean policy. The organization also manages ocean research and education programs in areas of scientific ocean drilling, ocean observing, ocean exploration, and ocean partnerships. The company was founded in 2007 and is headquartered in Washington, DC.

Key Stats and Financials As of 2018
Market Capitalization
Total Enterprise Value
Earnings Per Share
Revenue
$3.77B
Non-Profit Donations & Grants
Non-Profit Donations & Grants Received
Political Donations
Investments
Details Hidden

Heat Biologics, Inc. is a clinical stage company, which engages in the development of immunotherapies designed to activate and expand a patient's T-cell mediated immune system against cancer. The company's T-cell activating platform (TCAP) produces therapies designed to turn immunologically cold tumors to hot, and be administered in combination with checkpoint inhibitors and other immuno-modulators to increase clinical effectiveness. Its TCAP product candidates from the company's ImPACT and ComPACT platforms are produced from allogeneic cell lines expressing tumor-specific proteins common among cancers. The company was founded by Jeffrey Alan Wolf on June 10, 2008 and is headquartered in Morrisville, NC.

Suppliers
NV5 Global, Inc. Commercial Scientific Research | Hollywood, FL

NV5 Global, Inc. engages in the provision of professional and technical consulting and certification solutions for public and private sector. It operates through the Infrastructure (INF), and Building, Technology, and Sciences (BTS) segment. The INF segment covers engineering, civil program management, and construction quality assurance practices. The BTS segment includes energy, environmental and building program management practices. The company was founded on September 12, 2011 and is headquartered in Hollywood, FL.

OHL - Arellano Construction Co. Engineering, Construction & Architecture | Miami, FL

OHL - Arellano Construction Co. provides construction and renovation services. Its product offering includes a comprehensive list of construction and pre-construction services, estimating, scheduling, value engineering as well as selection of equipment and finishes. It works closely with architects, engineers and subcontractors to provide high-quality products and cost-effective options to its clients. The company was founded in 1973 and is headquartered in Miami, FL.

Skanska USA Building, Inc. Engineering, Construction & Architecture | Parsippany, NJ

Skanska USA Building Inc. provides construction, pre-construction consulting, general contracting, design-build and pharmaceutical validation services to the industries including pharmaceutical and biopharmaceutical, educational, high-tech, healthcare, aviation, transportation, sports and entertainment. The company was founded in 2001 and is headquartered in Parsippany, NJ.

Awards & Honors
Rank #124
2010
The Chronicle of Philanthropy - Philanthropy 400
Rank #96
2009
The Chronicle of Philanthropy - Philanthropy 400
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by University of Miami. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of University of Miami's profile does not indicate a business or promotional relationship of any kind between RelSci and University of Miami.